Pharmadrug Inc.
LMLLF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,005 | $3,102 | $5,437 | $13,133 |
| - Cash | $75 | $411 | $9 | $958 |
| + Debt | $1,349 | $1,767 | $1,423 | $866 |
| Enterprise Value | $2,279 | $4,457 | $6,851 | $13,041 |
| Revenue | $0 | $0 | $0 | $7 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$26 | -$2 | -$2 |
| % Margin | – | – | – | -30.7% |
| EBITDA | -$583 | -$1,335 | -$2,344 | -$4,208 |
| % Margin | – | – | – | -60,037.1% |
| Net Income | -$793 | -$13,201 | -$8,876 | -$5,874 |
| % Margin | – | – | – | -83,806.5% |
| EPS Diluted | -0.008 | -0.23 | -0.061 | -0.12 |
| % Growth | 96.7% | -275.8% | 49% | – |
| Operating Cash Flow | -$757 | -$672 | -$2,257 | -$4,125 |
| Capital Expenditures | -$12 | $0 | $0 | -$43 |
| Free Cash Flow | -$769 | -$672 | -$2,257 | -$4,168 |